pharmacy board; civil penalties.
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Overview
This bill amends Arizona’s pharmacy board regulations to increase civil penalties for violations of pharmacy laws and rules. Specifically, it updates sections related to the board’s powers, duties, and disciplinary actions, including the ability to charge fines for various infractions such as failing to update online profiles or comply with continuing education requirements. It also clarifies procedures for handling complaints and imposing sanctions, such as reprimands, suspensions, or revocations of permits, and establishes a process for issuing certificates of free sale for imported drugs.
Key provisions
- Increases civil penalties for pharmacy board violations, up to $25,000 per six-month period.
- Requires pharmacists and pharmacy interns to submit fingerprint clearance cards.
- Allows the board to investigate and address violations related to drug storage, security, and compliance.
- Establishes a process for issuing certificates of free sale for imported drugs and supplements.
- Defines procedures for disciplinary actions, including reprimands, suspensions, and revocations of permits.
- Clarifies the board’s authority to charge fees for inspections and other services.
- Outlines requirements for permittees to update online profiles and report changes.
- Details the board’s ability to enter into interim consent agreements with permittees facing imminent danger.
Who is affected
- Pharmacists
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
1 on record
Primary sponsor
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours